Gilead Sciences
Gilead Sciences is offering a 10–12 week summer internship within its Global Inflammation Regulatory Affairs Liaison team. The internship is designed for currently enrolled undergraduate or graduate students to gain real-world experience in a mission-driven biopharmaceutical company, culminating in a final presentation of work completed.
Headquarters
Foster City, California, United States
Company Size
10001+ employees
Founded
1987
Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD
4 hours ago
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals
1 hour ago
Jefferies initiates Gilead Sciences stock with buy rating
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Gilead Sciences.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
2 days ago
Senior Associate Clinical Trials Regulatory Affairs
Amgen
Regulatory Affairs Manager
Integrated Resources INC
Director, Principal Patient Safety Scientist
AstraZeneca
Regulatory Affairs Coordinator I
Mass General Brigham
Regulatory Strategy Manager
Neurocrine Biosciences
Senior Director, Regulatory Affairs
Annexon Biosciences